|
|
| YTD Return: |
N/A |
| 3y Avg Return: |
N/A |
| 5y Avg Return: |
N/A |
| Beta (3y): |
|
|
| The investment seeks to track the price and yield performance, before fees and expenses, of the HealthShares Metabolic-Endocrine Disorders Index.
The fund will invest at least 90% of assets in securities that comprise the index. The index consists of companies involved in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of metabolic-endocrine disorders. The fund is nondiversified. |
|
| Fund Profile |
|
Help
Summary
Add HHM to Portfolio 
Download Data
